Ocean Biomedical, Inc. (OCEA)
NASDAQ: OCEA · Real-Time Price · USD
0.127
-0.013 (-9.12%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ocean Biomedical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 1.38 | 9.51 | 7.71 | 28.41 | 1.6 | 0.2 |
| Research & Development | 0.01 | 0.71 | 8.41 | 33.93 | 0.05 | 0.04 |
| Operating Expenses | 1.39 | 10.21 | 16.12 | 62.35 | 1.65 | 0.23 |
| Operating Income | -1.39 | -10.21 | -16.12 | -62.35 | -1.65 | -0.23 |
| Interest Expense | -2.11 | -1.76 | -1.24 | - | - | - |
| Earnings From Equity Investments | -4.01 | -0.71 | - | - | - | - |
| Currency Exchange Gain (Loss) | - | - | - | 0 | - | - |
| Other Non Operating Income (Expenses) | -19.11 | -86.7 | 0.01 | - | -0 | - |
| EBT Excluding Unusual Items | -26.62 | -99.39 | -17.36 | -62.34 | -1.65 | -0.23 |
| Other Unusual Items | - | -15.08 | - | - | - | - |
| Pretax Income | -26.62 | -114.47 | -17.36 | -62.34 | -1.65 | -0.23 |
| Net Income | -26.62 | -114.47 | -17.36 | -62.34 | -1.65 | -0.23 |
| Net Income to Common | -26.62 | -114.47 | -17.36 | -62.34 | -1.65 | -0.23 |
| Shares Outstanding (Basic) | 27 | 26 | 23 | 17 | 17 | 17 |
| Shares Outstanding (Diluted) | 27 | 26 | 23 | 17 | 17 | 17 |
| Shares Change (YoY) | 8.17% | 12.58% | 33.56% | 0.19% | - | - |
| EPS (Basic) | -0.97 | -4.35 | -0.74 | -3.57 | -0.09 | -0.01 |
| EPS (Diluted) | -0.97 | -4.35 | -0.74 | -3.57 | -0.09 | -0.01 |
| Free Cash Flow | -2.53 | -9.43 | -0.99 | -1.05 | -0.06 | - |
| Free Cash Flow Per Share | -0.09 | -0.36 | -0.04 | -0.06 | -0.00 | - |
| EBIT | -1.39 | -10.21 | -16.12 | -62.35 | -1.65 | -0.23 |
Source: S&P Capital IQ. Standard template.
Financial Sources.